Position in CABA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,387,995
-$2,331,401 QoQ
Shares Held
1,410,931
-43.5% QoQ
Ownership
0.832%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 139 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CABA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,664,878 across 342 Biotechnology names. CABA ranks #123 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in CABA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,387,995 | 1,410,931 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,719,396 | 2,497,917 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,029,159 | 1,839,799 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,100,911 | 470,475 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $383,582 | 252,357 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $445,154 | 321,411 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,706,799 | 751,894 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,984,651 | 420,477 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,957,868 | 395,437 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $625,658 | 36,674 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,697,755 | 74,791 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $711,154 | 46,725 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $593,743 | 45,991 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $700,237 | 84,672 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $132,275 | 14,300 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $24,737 | 38,058 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $101,982 | 96,210 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $304,355 | 149,929 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $259,868 | 68,567 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $964,652 | 79,330 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $109,288 | 12,708 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $375,191 | 33,801 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $207,979 | 16,665 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $130,231 | 12,014 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $154,589 | 13,877 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||